The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index.
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
Open accessAbstract
We review the physiology and pharmacology of two atypical fibroblast growth factors (FGFs)—FGF15/19 and FGF21—that can function as hormones. Both FGF15/19 and FGF21 act on multiple tissues to coordinate carbohydrate and lipid metabolism in response to nutritional status. Whereas FGF15/19 is secreted from the small intestine in response to feeding and has insulin-like actions, FGF21 is secreted from the liver in response to extended fasting and has glucagon-like effects. FGF21 also acts in an autocrine fashion in several tissues, including adipose. The pharmacological actions of FGF15/19 and FGF21 make them attractive drug candidates for treating metabolic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They are endogenous ligands of the farnesoid X receptor (FXR), their activation of FXR resulting in the release of fibroblast growth factor (FGF) 1943.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [43]
In the citing paper
“Unlike traditional FGFs, however, the FGF19 subfamily of FGFs, consisting of FGF19, FGF21, and FGF23, has reduced affinity for HSGAGs and diffuses into circulation to act on distal tissues (9, 106). Thus, these FGFs function as endocrine hormones.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Berglund, E. D., Kang, L., Lee, R. S., Hasenour, C. M., Lustig, D. G., Lynes, S. E., Donahue, E. P., Swift, L. L., Charron, M. J., & Wasserman, D. H. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00263.2010 · Cited by 100
RetractedFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Self-citationFibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Nutritional Regulation of the Insulin-Like Growth Factors*
Thissen, J., Ketelslegers, J., & Underwood, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,575
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citation
Research works printed but not linked: 1
- 10.1210/en.143.5.1741 · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 442
Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome
Bednarska, S., Fryczak, J., & Siejka, A. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155188 · Cited by 17
The role of bile acid metabolism in bone and muscle: from analytics to mechanisms
Herrmann, M., Blanco, G. R., Balasso, M., Sobolewska, K., Semeraro, M. D., Alonso, N., & Herrmann, W. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2323132 · Cited by 17
Marín, A., Morales, F., & Walbaum, B. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1406951 · Cited by 18
Fan, Z., Wang, C., Yang, T., Gao, T., Wang, D., Zhao, X., Guo, X., & Li, D. (2022) · Food & Function · doi:10.1039/d2fo00081d · Cited by 16
Jiang, S., Zhang, R., Li, H., Fang, Q., Jiang, F., Hou, X., Hu, C., & Jia, W. (2014) · Lifestyle Genomics · doi:10.1159/000367943 · Cited by 16
Bock, K. W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.08.022 · Cited by 17
Yue, W., Sun, X., & Du, T. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0423-y · Cited by 17
Intestinal Transporter-Associated Drug Absorption and Toxicity
Xue, Y., Ma, C., Hanna, I. H., & Pan, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_8 · Cited by 14
The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation
Lee, S. H., Choi, J. M., Jung, S. Y., Cox, A. R., Hartig, S. M., Moore, D. D., & Kim, K. H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.086 · Cited by 16
Mechanisms of action of hESC-secreted proteins that enhance human and mouse myogenesis
Yousef, H., Conboy, M. J., Mamiya, H., Zeiderman, M., Schlesinger, C., Schaffer, D. V., & Conboy, I. M. (2014) · Aging · doi:10.18632/aging.100659 · Cited by 16
Wang, Y., Liu, X., Pijut, S. S., Li, J., Horn, J., Bradford, E. M., Leggas, M. L., Barrett, T. A., & Graf, G. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m053454 · Cited by 16
Zhang, J.-L., Li, H., Bai, N., Xu, Y., Song, Q., Zhang, L., Wu, G., Chen, S., Hou, X., Wang, C., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01018-5 · Cited by 16
Mao, J., Wei, Y., Ni, Z., Zhang, J., Zhu, J., & Wang, H. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01169-x · Cited by 16
Signaling Pathways Governing Cardiomyocyte Differentiation
Mensah, I. K., & Gowher, H. (2024) · Genes · doi:10.3390/genes15060798 · Cited by 17
Chlorhexidine-containing chewing gum. Clinical documentation
Imfeld, T. N. (2006) · PubMed · doi:10.5167/uzh-2549 · Cited by 15
Exploring endocrine FGFs - structures, functions and biomedical applications
Phan, P. (2024) · International Journal of Biochemistry and Molecular Biology · doi:10.62347/palk2137 · Cited by 16
Targeting Bile-Acid Metabolism: Nutritional and Microbial Approaches to Alleviate Ulcerative Colitis
Jiang, X., Ren, J., Yu, G., Wu, W., Chen, M., Zhao, Y., & He, C. (2025) · Nutrients · doi:10.3390/nu17071174 · Cited by 16
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng, J. N., & Jin, T. (2024) · Medical Review · doi:10.1515/mr-2024-0018 · Cited by 17
FGF23 associated bone diseases
Liao, E. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0254-6 · Cited by 14
Reed, K. M., Mendoza, K. M., Strasburg, G. M., & Velleman, S. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.970243 · Cited by 14
PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol
Mehta, D., & Mehta, K. D. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00373.2016 · Cited by 13
Li, X., Ren, Y., Huang, G., Zhang, R., Zhang, Y., Zhu, W., & Yu, K. (2022) · Food & Function · doi:10.1039/d2fo01958b · Cited by 13
Head Over Hepatocytes for FGF21
Potthoff, M. J., & Finck, B. N. (2014) · Diabetes · doi:10.2337/db14-1185 · Cited by 13
Self-citationA variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolism.
Walters, J. R. F., & Appleby, R. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.03.38 · Cited by 13
Oral health status of children with syndromic craniosynostosis.
Dalben, G. D. S., Costa, B., & Gomide, M. R. (2006) · PubMed · Cited by 13
BAT Exosomes: Metabolic Crosstalk with Other Organs and Biomarkers for BAT Activity
Goody, D., & Pfeifer, A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_114 · Cited by 13
MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal
Zhang, Q., Zhu, Q., Deng, R., Zhou, F., Zhang, L., Wang, S., Zhu, K., Wang, X. R., Zhou, L., & Su, Q. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0259 · Cited by 13
Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome
Wang, Q., Zhang, P., Çakır, I., Mi, L., Cone, R. D., & Lin, J. D. (2021) · Diabetes · doi:10.2337/db21-0161 · Cited by 13
Xiong, F., Jiang, X. J., Wu, Y., Xiong, J., Chen, Y., Wang, B., Ye, X., & Liang, X. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176953 · Cited by 11
Characterization of FGF21 Sites of Production and Signaling in Mice
Sullivan, A. I., Jensen-Cody, S. O., Claflin, K. E., Vorhies, K., Flippo, K. H., & Potthoff, M. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae120 · Cited by 11
Self-citationHepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock
Sun, J., Zhang, Y., Adams, J. A., Higgins, C. B., Kelly, S. C., Zhang, H., Cho, K., Johnson, U. G., Swarts, B. M., Wada, S.-I., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114865 · Cited by 13
Zhu, Y., Ding, X., Fang, C., & Zhang, Q.-Y. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088914 · Cited by 12
Jahn, D., Sutor, D., Dorbath, D., Weiß, J., Götze, O., Schmitt, J., Hermanns, H. M., & Geier, A. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.12.007 · Cited by 12
Dorval, L., Knapp, B. I., Majekodunmi, O. A., Eliseeva, S. I., & Bidlack, J. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108858 · Cited by 13
Long, A., Liu, Y., Fang, X., Jia, L., Li, Z., Hu, J., Wu, S., Chen, C., Huang, P., & Wang, Y. (2023) · Cell Research · doi:10.1038/s41422-023-00782-7 · Cited by 11
FGF-21, a newcomer in the field of hypertension research
Eto, K. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2012.68 · Cited by 11
You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease
Varre, J. V., Holland, W. L., & Summers, S. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159125 · Cited by 11
Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
Zangerolamo, L., Carvalho, M. U. W. B. D., Velloso, L. A., & Barbosa, H. C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176248 · Cited by 11
Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
Ziros, P. G., Zagoriti, Z., Lagoumintzis, G., Kyriazopoulou, V. E., Iskrenova, R. P., Habeos, E. E., Sykiotis, G. P., Chartoumpekis, D. V., & Habeos, I. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162024 · Cited by 11
Zhang, J., Li, H., Zhou, H., Fang, L., Xu, J., Yan, H., Chen, S., Song, Q., Zhang, Y., Xu, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06252-6 · Cited by 11
Bhat, N., Esteghamat, F., Chaube, B., Gunawardhana, K., Mani, M., Thames, C., Jain, D., Ginsberg, H. N., Fernandes‐Hernando, C., & Mani, A. (2022) · The FASEB Journal · doi:10.1096/fj.202101607r · Cited by 11
Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis
Maitiabula, G., Tian, F., Wang, P., Zhang, L., Gao, X., Wan, S., Sun, H., Yang, J., Zhang, Y., Gao, T., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.008 · Cited by 11
Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis
Romain, G., Tremblay, S., Arena, E. T., Antunes, L. C. M., Covey, S. D., Chow, M., Finlay, B. B., & Menéndez, A. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-238 · Cited by 11
Role of fibroblast growth factor 19 in maintaining nutrient homeostasis and disease.
Zhang, J., Li, H. T., Fang, Q. C., & Jia, W. (2014) · PubMed · doi:10.3967/bes2014.056 · Cited by 11
Zhang, J., Li, Y., Liu, Y., Ma, N., Qian, S., Chen, Y., Duan, Y., Xiang, X., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01267-9 · Cited by 10
Growth Factors in the Intestinal Tract
Schumacher, M. A., Danopoulos, S., Alam, D. A., & Frey, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00003-7 · Cited by 10
Poloczek, J., Kazura, W., Kwaśnicka, E., Gumprecht, J., Jochem, J., & Stygar, D. M. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5527107 · Cited by 10
The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury
Wen, Y., Zhang, G., & Wu, X. (2022) · Toxicology · doi:10.1016/j.tox.2022.153256 · Cited by 9
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
Sadowska, A., Poniedziałek‐Czajkowska, E., & Mierzyński, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417298 · Cited by 9
Jayanti, S. D., Vı́tek, L., Verde, C. D., Llido, J. P., Sukowati, C. H. C., Tiribelli, C., & Gazzin, S. (2024) · Biomolecules · doi:10.3390/biom14010063 · Cited by 10
Fisher, F. M., & Maratos–Flier, E. (2013) · Nature Medicine · doi:10.1038/nm.3058 · Cited by 9
The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
Jagodzińska, A., Chudecka-Glaz, A. M., Michalczyk, K., Pius‐Sadowska, E., Wieder-Huszla, S., Jurczak, A., & Machaliński, B. (2023) · Diagnostics · doi:10.3390/diagnostics13030399 · Cited by 9
Kanbay, M., Mutlu, A., Bakır, Ç. N., Peltek, İ. B., Canbaz, A. A., Díaz‐Tocados, J. M., & Haarhaus, M. L. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae066 · Cited by 8
Si-Ni-San ameliorates cholestatic liver injury by favoring P. goldsteinii colonization.
Li, F., Han, Q., Cai, Y.-J., Li, Y.-F., Yang, Y., Li, J.-N., Wu, R.-Y., Chen, R.-Y., & Liu, R.-P. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118804 · Cited by 12
Du, Y., Xiao, H., Luo, R., Li, G., & Ren, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1606223 · Cited by 8
Suzuki, M., Lee, A. Y., Vázquez‐Medina, J. P., Viscarra, J. A., Crocker, D. E., & Ortiz, R. M. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.03.009 · Cited by 8
Fangmann, D., Geisler, C., Schlicht, K., Hartmann, K., Köpke, J., Tiede, A., Settgast, U., Türk, K., Schulte, D. M., Altmann, K., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.006 · Cited by 8
Chen, W., Shen, Z., Cai, S., Chen, L., & Wang, D. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/133494 · Cited by 8
Growth Hormone and IGF-1 Axis in Aging and Longevity
Shimokawa, I. (2017) · Healthy ageing and longevity · doi:10.1007/978-3-319-63001-4_5 · Cited by 8
Feng, J. N., Shao, W., Yang, L., Pang, J., Ling, W., Liu, D., Wheeler, M. B., He, H. H., & Jin, T. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00363-0 · Cited by 7
Functions of Cholesterol Metabolites
Sato, R. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.s151 · Cited by 7
Pathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_9 · Cited by 9
Cai, W., Li, C., Su, Z., Cao, J., Chen, Z., Chen, Y., Guo, Z., Cai, J., & Xu, F. (2023) · PeerJ · doi:10.7717/peerj.16407 · Cited by 8
Hajizadeh, M., Mohammad-Sadeghipour, M., Mahmoodi, M., Falahati‐pour, S. K., Khoshdel, A., Fahmidehkar, M., Mirzaei, M., & Karimabad, M. (2019) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.260396 · Cited by 7
Biology, pathophysiology, and epidemiology of pancreatic cancer
Dariya, B., Alam, A., & Nagaraju, G. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00001-3 · Cited by 7
Manithody, C., Denton, C., Price, A., Blomenkamp, K., Patel, Y., Welu, A., Glbert, E., Madnawat, H., Jain, S., Villalona, G. A., et al. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220915881 · Cited by 7
Polyguluronate sulfate and its oligosaccharides but not heparin promotes FGF19/FGFR1c signaling
Lan, Y., Zeng, X., Guo, Z., Zeng, P., Hao, C., Zhao, X., Yu, G., & Zhang, L. (2017) · Journal of Ocean University of China · doi:10.1007/s11802-017-3195-x · Cited by 7
Wang, J., Sheu, W. H., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Lin, S. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.07.017 · Cited by 6
Virtuoso, A., Forkman, B., Sarruf, D. A., Tveden‐Nyborg, P., & Sørensen, D. B. (2017) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2017.10.012 · Cited by 6
Wang, N., Sun, B., Guo, H., Jing, Y., Qi, R., Wang, M., Mi, Y., Chen, H., Song, L., & Cui, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795520 · Cited by 6
Tiwari, N. (2024) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2024.16768 · Cited by 5
The role of fibroblast growth factor 19 in the pathogenesis of nonalcoholic fatty liver disease
Chrysavgis, L., Giannakodimos, I., Chatzigeorgiou, A., Τζιόμαλος, Κ., Papatheodoridis, G., & Cholongitas, Ε. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2127408 · Cited by 5
Wang, J., Lee, C.-L., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.006 · Cited by 5
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00003-x · Cited by 5
Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4
UPRmt-regulated mitokines: novel strategies for myocardial injury repair
Gao, W., Liu, J., Zhang, W., Liu, B., & Shen, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1652353 · Cited by 4
Li, J., Wang, Y., Li, R., Huang, H., Zhu, X., Li, X., Sun, Z., Zhang, L., Zheng, P., He, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.017 · Cited by 7
Tawil, J., Vaca, F., & Schmulson, M. J. (2021) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.21000003 · Cited by 4
Galal, A., El-Bakly, W. M., El-Kilany, S. S., Ali, A. A., & El-Demerdash, E. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000656 · Cited by 4
Qureshi, H. A. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000158 · Cited by 4
Liver regeneration: cytokine regulation targeting hepatocytes and beyond
Xiao, T., Jin, Z., Deng, J., & Meng, W. (2026) · Life Medicine · doi:10.1093/lifemedi/lnag004 · Cited by 4
Song, J., Wang, Y., Guo, R., Wang, K. Y., Hu, Y., Cui, M., Wang, G., Hao, H., Wang, H., & Xu, X. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178910 · Cited by 3
Pathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_8 · Cited by 3
Yuan, Z., He, J., Li, Z., Fan, B., Zhang, L., & Man, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189196 · Cited by 3
Xie, J., Shao, Y., Liu, J., Cui, M., Xiao, X., Gong, J.-B., Xue, B., Zhang, Q., Hu, X., & Duan, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-77096-w · Cited by 3
Guerrero, J. G., Ishida, E., Shibusawa, N., Lei, X., Yamada, S., Horiguchi, K., & Yamada, M. (2022) · Thyroid · doi:10.1089/thy.2022.0144 · Cited by 3
Fibroblast Growth Factor 21 is a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Matikainen, N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00039-8 · Cited by 3
Matta, R., El-Hini, S. H., Saad, M., Mostafa, H., & AbedelfadeeL, A. (2017) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/ejode.ejode_30_16 · Cited by 3
How Sweet It Is To Activate FXR
Jansen, P. L. M., & Schaap, F. G. (2013) · Hepatology · doi:10.1002/hep.26778 · Cited by 3
Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Matikainen, N., & Söderlund, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00013-6 · Cited by 2
Jain, U., Srivastava, P., Sharma, A., Sinha, S., & Johari, S. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998265915231116043813 · Cited by 3
Shinozaki, H., Kawai, S., Gamo-Kawasaki, M., Takei, A., Tsujikado, K., Fukuda, K., Yamauchi, M., Hara, K., Tsuchiya, T., Takebayashi, K., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0570 · Cited by 2
Wang, Y., Zhang, H., Zhan, Y., Li, Z., Li, S., & Guo, S. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01496-z · Cited by 2
Moore, A. L., Marshall, C. D., Nauta, A., Lorenz, H. P., & Longaker, M. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00005-9 · Cited by 2
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., Koehler, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522509 · Cited by 2
Self-citationThe Role of The βklotho Gene, Fgf21 and Fgfr1 in Cancerogenesis
Wójcik‐Krowiranda, K., Szczepaniec, S., & Bieńkiewicz, A. (2018) · Women Health Care and Issues · doi:10.31579/2642-9756/003 · Cited by 1
Li, Y., Zhang, Y., & Li, X. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2590058 · Cited by 2
Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue
Guerrero, J. J. G., Encarnacion, P. C., Wang, C., del Rosario, M. A. S., Notarte, K. I., Zhou, J., Hsieh, Y.-T., Wang, W.-Y., Chang, C.-W., & Li, W.-C. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00699-3 · Cited by 2
Duodenal Transit Bipartition: A Versatile Metabolic Procedure
Kfouri, D. S., de Melo, P. R. R. E., Madalosso, C. A. S., Dib, V. R. M., Noe͏̈l, P., de Godoy, E. P., Beltran, G., Ávalos, M. A., Ribeiro, R. J. D. S., d’Almeida, L. A. V., et al. (2026) · Surgical Science · doi:10.4236/ss.2026.178033 · Cited by 1
Adult-onset deficiency of β-klotho in the liver reveals a novel role in lipid homeostasis
Aaldijk, A. S., Verzijl, C. R. C., Hovingh, M. V., Huijkman, N., Smit, M., Kloosterhuis, N., Mulder, N. L., Havinga, R., Gerding, A., Bos, T., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102443 · Cited by 1
Metadata
- Authors
- Potthoff, M. J., Kliewer, S. A., & Mangelsdorf, D. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-02-02
- Volume
- 26
- Issue
- 4
- Pages
- 312-324
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3289879
- OpenAlex
- W2099579483
- Cited by
- 442
- References
- 141
- Citations by year
- 2026: 19 · 2025: 13 · 2024: 30 · 2023: 16 · 2022: 37 · 2021: 30 · 2020: 29 · 2019: 27 · 2018: 39 · 2017: 41 · 2016: 28 · 2015: 36 · 2014: 46 · 2013: 37 · 2012: 12
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute (I-1558, I-1275)
- Welch Foundation (I-1275, I-1558)
- National Institutes of Health (I-1275, I-1558)
- National Institute of General Medical Sciences (RL1GM084436)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK067158)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- FGF15/19, FGF21, carbohydrate metabolism, lipid metabolism, nutritional status, fasting, insulin-like activity, autocrine signaling, adipose tissue, small intestine, liver
- MeSH terms
- Animals, Bile Acids and Salts, Fasting, Fibroblast Growth Factors, Homeostasis, Humans, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review